A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente ...

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...

The details of the presentation will be accessible in the Investor section of the CervoMed website following the presentation. CervoMed Inc. is a clinical-stage company focused on developing ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

However, medical conditions can sometimes affect posture. According to the Alzheimer’s Society, those with Lewy body dementia experience movement difficulties, such as changes to their posture ...

A number of blood tests have shown promise in research studies but aren’t routinely used in diagnosing dementia.

A new study published in Alzheimer’s & Dementia highlights a significant step forward in diagnosing Dementia with Lewy Bodies ...